NCT00004246View on ClinicalTrials.gov

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 7, 1995

Primary Completion Date

December 2, 2002

Study Completion Date

December 2, 2002

Conditions
Head and Neck Cancer
Interventions
DRUG

Fludarabine Phosphate

IV on days 1-5 of weeks 6 and 7 of radiotherapy, administered 3-4 hours prior to daily radiotherapy.

RADIATION

Radiation Therapy (RT)

Days 1-5 for 7 weeks

Trial Locations (1)

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00004246 - Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx | Biotech Hunter | Biotech Hunter